|
Centronuclear Myopathy (CNM1) |
approved
|
160150 |
|
|
|
|
Cerebellar Ataxia, Intellectual Disability and Dysequilibrium Syndrome Type 1 |
approved
|
224050 |
|
|
|
|
Cerebellar Ataxia, Intellectual Disability and Dysequilibrium Syndrome Type 2 |
approved
|
610185 |
|
|
|
|
Cerebellar Ataxia, Intellectual Disability and Dysequilibrium Syndrome Type 3 |
approved
|
613227 |
|
|
|
|
Cerebellar Ataxia, Intellectual Disability and Dysequilibrium Syndrome Type 4 |
approved
|
615268 |
|
|
|
|
Cerebral Autosomal Dominant Arteriopathy with Sub cortical infarcts and Leukoencephalopathy (CADASIL) |
approved
|
125310 |
|
|
|
|
Cerebral Cavernous Malformations (CCM) |
approved
|
116860 |
|
|
Cerebral Cavernous Malformations 3 (CCM3) |
approved
|
603285 |
|
|
|
|
Cerebral Creatine Deficiency Syndrome 1 (CCDS1) |
approved
|
300352 |
|
|
|
|
Cerebral Creatine Deficiency Syndrome 2 (CCDS2) |
approved
|
612736 |
|
|
|
|
Cerebral Creatine Deficiency Syndrome 3 (CCDS3) |
approved
|
612718 |
|
|
|
|
Cerebro-oculo-facial-skeletal syndrome Type 1 (COFS1) |
approved
|
214150 |
|
|
|
|
Cerebro-oculo-facial-skeletal syndrome Type 2 (COFS2) |
approved
|
610756 |
|
|
|
|
Cerebro-oculo-facial-skeletal syndrome Type 3 (COFS3) |
approved
|
616570 |
|
|
|
|
Cerebro-oculo-facial-skeletal syndrome type 4 (COFS4) |
approved
|
610758 |
|
|
|
|
Ceroid Lipofuscinosis, Neuronal, type 1 (CLN1) |
approved
|
256730 |
|
|
Ceroid Lipofuscinosis, Neuronal, type 1 (CLN1) |
approved
|
256740 |
|
|
|
|
Ceroid Lipofuscinosis, Neuronal, type 10 (CLN10) |
approved
|
610127 |
|
|
|
|
Ceroid Lipofuscinosis, Neuronal, Type 2 (CLN2) |
approved
|
204500 |
|
|
|
|
Ceroid Lipofuscinosis, Neuronal, type 5 (CLN5) |
approved
|
256731 |
|
|
|
